Focus: Alpha-9 Oncology is a radiopharmaceutical specialist focused on targeted cancer therapeutics, headquartered in Vancouver, BC. The company is in early-stage clinical development with a pipeline concentrated in alpha-emitter radiopharmaceuticals for solid tumors.
Profile data last refreshed 18h ago · AI intelligence enriched 2w ago
Stable — net +2 jobs in 30d
2 added, 0 removed. Backfill posture.
Best suited for early-career or senior specialists willing to accept startup risk in exchange for deep radiopharmaceutical expertise and equity upside.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Alpha-9 Oncology
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Alpha-9 Oncology's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Based on last 4 crawl cycles
Recent peer-reviewed publications with author affiliations at this company
Showing 5 of 10 publications
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo